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A novel phospho-modulatory 
mechanism contributes to the 
calcium-dependent regulation of 
t-type ca2+ channels
Jean chemin1,2*, Tamara Timic Stamenic  3, Magalie cazade1,2, Jodie Llinares1,2, 
iulia Blesneac1,2, Slobodan M. todorovic3 & philippe Lory1,2
cav3 / T-type Ca2+ channels are dynamically regulated by intracellular ca2+ ions, which inhibit Cav3 
availability. Here, we demonstrate that this inhibition becomes irreversible in the presence of non-
hydrolysable ATP analogs, resulting in a strong hyperpolarizing shift in the steady-state inactivation of 
the residual cav3 current. Importantly, the effect of these ATP analogs was prevented in the presence 
of intracellular BAPTA. Additional findings obtained using intracellular dialysis of inorganic phosphate 
and alkaline phosphatase or nan3 treatment further support the involvement of a phosphorylation 
mechanism. Contrasting with Cav1 and Cav2 Ca2+ channels, the Ca2+-dependent modulation of cav3 
channels appears to be independent of calmodulin, calcineurin and endocytic pathways. Similar 
findings were obtained for the native T-type Ca2+ current recorded in rat thalamic neurons of the central 
medial nucleus. Overall, our data reveal a new Ca2+ sensitive phosphorylation-dependent mechanism 
regulating cav3 channels, with potentially important physiological implications for the multiple cell 
functions controlled by t-type ca2+ channels.
Voltage-gated Ca2+ channels (VGCCs) are widely expressed in neurons, heart and muscles where they contribute 
to many critical physiological functions including cellular excitability but also muscle contraction, neurotrans-
mitter release and gene expression1. An alteration in VGCC function leads to several diseases, including epilepsy, 
ataxia, chronic pain as well as cardiac pathologies1,2. Therefore, VGCC activity is tightly regulated by multiple 
intracellular pathways, including Ca2+ ions, which provide an important feedback control of Ca2+ homeostasis3,4.
VGCCs are divided into three families: the L-type channels (Cav1 family); the neuronal N-, P/Q-, and R-type 
channels (Cav2 family); and the T-type channels (Cav3 family)5. The Cav3 channels display unique electrophysio-
logical features including a low-voltage-activated Ca2+ current, fast inactivation kinetics and a strong steady-state 
inactivation at physiological resting potentials6,7. These electrophysiological properties of T-type channels allow 
the generation of low-threshold spikes in neurons subsequent to transient membrane hyperpolarization6,7. 
Low-threshold spikes mediate rebound burst firing, which have important physiological implication, especially 
in thalamo-cortical circuit where T-type channels control transition between awake and sleep states6–9. T-type 
channels are also implicated in several neuronal disorders including epilepsy, chronic pain, autism, schizophrenia 
and cerebellar ataxia2,8,10–12. Consequently, the understanding of T-type channel regulation is of great physiolog-
ical importance.
In contrast with Cav1 and Cav2 VGCCs, for which the regulation by intracellular Ca2+ has been extensively 
studied3,4,13,14, the regulation of Cav3 channels by Ca2+ ions has been underappreciated until recently15–18. We 
have previously shown that the Cav3.3 current (and to a lesser extend the Cav3.1 current but not the Cav3.2 cur-
rent) is inhibited at a fast frequency of stimulation, providing an important feedback control15. This inhibition 
is associated with faster current inactivation kinetics and a negative shift in the steady-state inactivation of the 
Cav3.3 current. Interestingly, these effects are observed when recording Cav3.3 inward current but not Cav3.3 
outward current indicating that a role of a voltage-dependent inactivation is unlikely15. Furthermore the cur-
rent inhibition is abolished in the presence of intracellular BAPTA but not EGTA, indicating the involvement of 
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submembrane Ca2+ ions. However, Ca2+ ions have no effect on the Cav3.3 current recorded in cell-free inside-out 
patches indicating the necessity of an intracellular transduction pathway that takes place in the intact cells. For 
the Cav1 and Cav2 VGCCs, several studies have indicated that, depending of the amount of the Ca2+ entry, the 
Ca2+-dependent regulation of these channels mainly involves activation of calmodulin19–22 and calcineurin23,24 
as well as Ca2+-dependent endocytosis of the channels21,25,26. We therefore investigated whether any of these 
Ca2+-dependent processes could be involved in the high frequency stimulation-induced inhibition of Cav3.3 
current or its recovery following termination of the stimulation. Our results demonstrate that this Cav3.3 current 
modulation does not depend on calmodulin, calcineurin or endocytosis of the channels but is regulated by a 
phosphorylation-dependent process. We found that a Ca2+-dependent phosphorylation controls the availability 
of Cav3 channels by adjusting the voltage-dependence of the steady-state inactivation curve. Similar findings were 
observed on native T-type channels expressed in the central medial nucleus of the thalamus, in which T-type 
channels mediate rebound burst firing27. Hence, our findings strongly suggest the involvement of a novel Ca2+ / 
phosphorylation-dependent transduction pathway that finely adjusts the T-type channel properties necessary for 
proper physiological function.
Results
At high frequency stimulation, the Cav3.3 current displays a Ca2+-dependent inhibition that is dynamically reg-
ulated15. During stimulations applied at 1 Hz frequency, the Cav3.3 current decreased ~45% from its initial value 
after 40 seconds (p < 0.001, Fig. 1A,B) and this decrease was associated with faster inactivation kinetics (p < 0.001, 
Fig. 1C). Stopping the stimulation for 3 minutes allowed a full recovery of Cav3.3 current amplitude, after which 
Cav3.3 current decrease at fast stimulation could be reproduced several times (Fig. 1A, 2nd and 3rd). Applying 
this protocol 3 times (Fig. 1A) allowed us to quantify both the current inhibition and its recovery after the 1st 
and the 3rd stimulation. Quantification of current inhibition and current recovery was calculated as the ratio of 
the current amplitude obtained at the 3rd stimulation before and after the 1 Hz stimulation to the initial current 
amplitude obtained at the 1st stimulation (I 1 s 1st; Fig. 1B). Taking advantage of the reversibility and reproduci-
bility of the Ca2+-dependent inhibition of the Cav3.3 current, we investigated the mechanisms underlying current 
decrease as well as current recovery.
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Figure 1. The Cav3.3 current inhibition induced by stimulation at 1 Hz frequency (activity-dependent) is 
reversible and reproducible. (A) Typical examples of Cav3.3 currents elicited by a test pulse stimulation at −30 
mV (450 ms duration) applied at a frequency of 1 Hz from a holding potential (HP) of −100 mV. The traces 
obtained at the beginning of the stimulation (1 s) and after 40 s stimulation are indicated in blue and red, 
respectively. Stopping the stimulation for 3 minutes allows the recovery of the Cav3.3 current. The protocol 
was applied 3 times and the time course of the current amplitude is indicated as an inset. (B) Amplitude of the 
Cav3.3 current at the beginning (1 s) and after 40 s obtained at the 1st and the 3rd stimulation normalized to the 
initial current amplitude obtained at the beginning of the 1st stimulation: I (1 s 1st), n = 21. (C) Inactivation 
kinetics of the Cav3.3 current at the beginning of the stimulation (1 s) and after 40 s obtained for the 1st and 
the 3rd stimulation (n = 21). Asterisks indicate significant difference as compared to the initial current (1 s 1st) 
amplitude (B) and inactivation kinetics (C). (n.s.: non-significant).
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It has been demonstrated that a prolonged Ca2+ entry induces an internalization of the L-type channels 
via endocytosis, possibly leading to degradation in the lysosome21,25,26. We tested whether this pathway was 
implicated in the inhibition of Cav3.3 current during fast stimulation (Supplementary Fig. 1). Endocytosis was 
disrupted by expressing a dominant negative mutant of dynamin 1 (Dyn 1 K44A), a GTPase required for the 
formation of endocytic vesicles from the plasma membrane and implicated in the endocytosis of the L-type 
channel25,28. Expression of the Dyn 1 K44A mutant (Supplementary Fig. 1B) did not alter the inhibition of the 
Cav3.3 current during fast stimulation (~45%, p < 0.001, red bars in Supplementary Fig. 1E) as compared to WT 
dynamin or the control condition (p > 0.05, Supplementary Fig. 1A,E). In addition, the recovery of the Cav3.3 
current was not different in cells expressing the Dyn 1 K44A mutant (blue bars in Supplementary Fig. 1E) as 
compared to WT dynamin or the control condition (p > 0.05, Supplementary Fig. 1A,E). Similar findings were 
obtained after expression of the adaptor protein 2 (AP-2), a central player in clathrin-mediated endocytosis29, 
which did not modify current inhibition (~45%, p < 0.01) or its recovery (Supplementary Fig. 1C,E), as compared 
to the control condition (p > 0.05, Supplementary Fig. 1E). In addition, we have treated the cells with the lysoso-
mal inhibitor bafilomycin (100 nM, 3–5 hours), using the same protocol as described for L-type channels26. We 
found that bafilomycin did not affect Cav3.3 current inhibition at a high frequency of stimulation, nor its recovery 
(Supplementary Fig. 1D,E). The analysis of the Cav3.3 current also indicated no significant effect of dynamin 
K44A, AP2 or bafilomycin treatment on current inactivation kinetics at the beginning as well as at the end of the 
fast stimulation protocol, as compared to the respective control condition (p > 0.05, n = 5–6).
Calmodulin (CaM) is important for the modulation of the L-type current19–22 and has emerged recently as 
a modulator of T-type channels, including Cav3.316–18. To investigate this pathway we first used a CaMKII pep-
tide (100 µM CaMKII 290–309) that binds CaM and inhibits its function and additional calmodulin-requiring 
enzymes. Dialysis of this peptide did not modify the Cav3.3 current inhibition at 1 Hz frequency of stimula-
tion, nor its recovery (p > 0.05, as compared to the control condition, Fig. 2A,E). We next used a CaM mutant, 
CaM1234, which is unable to bind Ca2+ and was previously used to demonstrate the CaM regulation of the L-type 
channel19,20. Expression of this mutant was also without significant effect on Cav3.3 modulation (Fig. 2B,E), indi-
cating that CaM was not involved in the decrease of Cav3.3 current induced by stimulation at a high frequency 
or in its recovery. Similar results were obtained using the CaMKII inhibitory peptide (autocamtide-2-related 
inhibitory peptide, AIP, 100 µM intrapipette) and STO-609, a CaMKK inhibitor (1 µM incubation for 2 hours; 
Fig. 2C–E). In addition, the current inactivation kinetics at the beginning and at the end of the fast stimulation 
protocol were not significantly modified by CaMKII and AIP peptides or CaM1234 and STO-609, as compared to 
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Figure 2. Calmodulin and CaMKII are not involved in the activity-dependent Cav3.3 current inhibition. 
(A–D) Examples of Cav3.3 currents elicited by the 1 Hz stimulation protocol during 40 s for the 1st and the 3rd 
stimulation in cells dialyzed with 100 µM CaMKII peptide (A), in cells expressing CaM1234 (B), in cells dialyzed 
with 100 µM autocamtide-2-related inhibitory peptide, AIP (C), and in cells treated for 2 hours with 1 µM STO-
609 (D). (E) Amplitude of the Cav3.3 current at the beginning (1 s) and after 40 s obtained during the 1st and 
the 3rd stimulation normalized to the initial current amplitude obtained at the beginning of the 1st stimulation 
I (1 s 1st). Asterisks indicate significant difference in the current amplitude, as compared to the initial current 
amplitude. In addition, the current inhibition (red bars) and recovery (blue bars), as function of the treatment, 
was statistically compared to the respective control condition, as indicated. The number of cells tested is 
indicated into brackets. (n.s.: non-significant).
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the respective control condition (p > 0.05, n = 5–8). However, we found that CaM1234 expression induced a nega-
tive shift ~5.5 mV in the steady-state inactivation of the Cav3.3 current (n = 8, p < 0.005) compared to the control 
condition (n = 5), as recently reported for the Cav3.2 current17.
It was also demonstrated that during 1 Hz frequency stimulation, the L-type current decreases similarly to 
the Cav3.3 current and that this effect is mediated in part by calcineurin23,24. We have therefore tested whether 
this pathway was implicated in the Cav3.3 current decrease. Cells were treated with a combination of cyclo-
sporin A and FK506 (10 µM each) before patch-clamp experiments, a treatment that prevents the decrease and 
the calcium-dependent inactivation (CDI) of the L-type current23,24. We found that 1–2 hours incubation with 
cyclosporin A and FK506 did not affect the decrease of the Cav3.3 current, nor its recovery, as compared to vehi-
cle (DMSO)-treated cells (p > 0.05, Fig. 3A,B,E). Similarly, inclusion of the calcineurin inhibitory peptide (CIP, 
100 µM in the patch pipette), which also prevents L-type current decrease and CDI23,24, did not affect the Cav3.3 
current modulation (Fig. 3C,E). We also found that both inhibition and recovery of the Cav3.3 current were unaf-
fected by okadaic acid (100 nM overnight incubation and 1 µM in the patch pipette) or by deltamethrin (10 µM 
in the patch pipette) (Fig. 3D,E). In addition, none of the compounds tested modified the current inactivation 
kinetics at the beginning and at the end of the fast stimulation protocol (p > 0.05, as compared to the control 
condition, n = 5–9). Similarly, no significant change on the steady-state inactivation of the Cav3.3 current was 
observed (p > 0.05, as compared to the control condition, n = 7–14). Overall, these findings strongly suggest that 
neither endocytosis nor CaM-dependent pathways nor calcineurin play a significant role in the Cav3.3 current 
modulation at a high frequency of stimulation, which therefore requires different molecular mechanisms than 
those previously described for the L-type channel.
In order to investigate further the role of a phosphorylation mechanism in Cav3.3 current modulation, we 
used inorganic phosphate to compete with phosphatase activities30,31. Inorganic phosphate (Pi, 10 mM KH2PO4) 
was applied via the patch pipette 10 minutes before stimulation of the Cav3.3 current. In the presence of intracel-
lular Pi, fast stimulation induced a slight current decrease ~20% (p < 0.05, Fig. 4B,C) whereas the current decrease 
was ~45% in the control condition (15 mM KCl in the patch pipette, p < 0.001, Fig. 4A,B). In average, the current 
decrease in the presence of Pi was ~35% less than the control value at the 3rd stimulation (p < 0.01; Fig. 4C), 
whereas there was a slight but not significant increase in current recovery (Fig. 4C). In addition, during the 
stimulation at 1 Hz frequency, the acceleration in the inactivation kinetics was less pronounced in the presence 
of intracellular Pi as compared to the control condition (p < 0.05, Fig. 4D). It should be noted that in addition to 
competing with phosphatase activities, KH2PO4 may bind Ca2+ and therefore may act as a Ca2+ buffer. However, 
100 ms
400 pA
1 s
40 s
1 s
40 s
1st 3rd
100 ms
400 pA
Ctrl (DMSO)
CIP
100 ms
400 pA
100 ms
400 pA
1st 3rd
1 s
40 s
1 s
40 s
Cyclosporine A + FK506
100 ms
400 pA
1 s
40 s
1 s
40 s
1st 3rd
100 ms
400 pA
Okadaic acid
100 ms
400 pA
1 s
40 s
1 s
40 s
1st 3rd
100 ms
400 pA
A B
C D
C
trl
(6)
C
trl
(6)
C
yc
lo
.A
+
FK
50
6
n.s.
(6)
C
IP
n.s.
(9)
O
ka
da
ic
ac
id
n.s.
(8)
D
el
ta
m
et
hr
in
n.s.
(5)
C
trl
(6) (6)
C
IP
(9)
O
ka
da
ic
ac
id
(8)
D
el
ta
m
et
hr
in
(5)
C
yc
lo
.A
+
FK
50
6
(6)
C
IP
(9)
O
ka
da
ic
ac
id
(8)
D
el
ta
m
et
hr
in
(5)
n.s.
0
1
0.25
0.5
0.75
40 s 3rd
1 s 3rd1 s 1st
40 s 1st
E I / I (1s 1st)
***
C
yc
lo
.A
+
FK
50
6
************
***
******
******
n.s.
n.s.
n.s.
Figure 3. Calcineurin and okadaic acid sensitive phosphatases are not involved in the activity-dependent 
Cav3.3 current inhibition. (A–D) Examples of Cav3.3 currents elicited by the 1 Hz stimulation protocol during 
40 s for the 1st and the 3rd stimulation in the control condition (A), in the presence of 10 µM cyclosporin A and 
10 µM FK506 (B), in the presence of 100 µM calcineurin inhibitory peptide (CIP) (C), and in the presence of 
1 µM okadaic acid (D). (E) Amplitude of the Cav3.3 current at the beginning (1 s) and after 40 s obtained at the 
1st and the 3rd stimulation normalized to the initial current amplitude I (1 s 1st). Asterisks indicate significant 
difference in the current amplitude, as compared to the initial current amplitude. In addition, the current 
inhibition (red bars) and recovery (blue bars), as function of the treatment, was statistically compared to the 
respective control condition, as indicated. The number of cells tested is indicated into brackets. (n.s.: non-
significant).
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we observed a similar decrease in Cav3.3 current in the cells dialyzed with an intracellular solution containing 
20 mM EGTA, as compared to our standard recording condition using 10 mM EGTA (p > 0.5, n = 17), suggesting 
that the Pi effect does not rely on its Ca2+ buffer property. Moreover, these results suggest that a Ca2+-driven phos-
phatase might be responsible for the current decrease (see schematic representation in Supplementary Fig. 7). In 
agreement with the involvement of a phosphorylation mechanism, inclusion of recombinant alkaline phosphatase 
(AP, 100 U/ml) in the patch pipette32 “mimicked” the inhibition of the Cav3.3 current at 1 Hz frequency stimula-
tion (Supplementary Fig. 2A,B) and induced an acceleration in the current inactivation kinetics (Supplementary 
Fig. 2A–C). Importantly, the remaining current after AP treatment was stable during the 1 Hz frequency stim-
ulation protocol (Supplementary Fig. 2A,B). In addition, the steady-state inactivation of the Cav3.3 current was 
largely shifted towards negative potentials after AP dialysis (~25 mV, p < 0.001; Supplementary Fig. 2D).
Considering that current inhibition could result from a phosphatase activity, we investigated whether a puta-
tive kinase activity might be implicated in current recovery (see schematic representation in Supplementary 
Fig. 7). To this purpose, the cells were incubated in the presence of 10 mM sodium azide (NaN3), which inhibits 
mitochondrial function33 and thereby results in a depletion of intracellular ATP (Fig. 5A,B). In the presence of 
NaN3 (and in the absence of ATP in the patch pipette), the 1 Hz stimulation induced a strong inhibition of the 
Cav3.3 current (~70%, p < 0.001, Fig. 5C), which is significantly larger than that observed in the control condition 
(p < 0.001, Fig. 5C). Interestingly the recovery of the current at the 3rd stimulation was completely abolished after 
NaN3 treatment and the residual current displayed fast inactivation kinetics (p < 0.001, Fig. 5C,D), suggesting that 
the recovery of the Cav3.3 current relies on an ATP-dependent mechanism. We therefore investigated whether 
the hydrolysis of the phosphate group from ATP is needed for current recovery. To this end we tested the effect of 
non-hydrolysable ATP analogs (Fig. 6). When intracellular ATP in the patch pipette was replaced by AMP-PCP, 
the inhibition of the Cav3.3 current (~55%, p < 0.001) at 1 Hz frequency stimulation was not significantly mod-
ified as compared to the control condition (p > 0.05, Fig. 6A,B,E), but the recovery of the Cav3.3 current was 
completely abolished (p < 0.001; Fig. 6A,B,E). Similar findings were observed using another non-hydrolysable 
ATP analog, AMP-PNP, which completely abolished the recovery of the Cav3.3 current (p < 0.001; Fig. 6C,E) 
but did not modify current inhibition as compared to the control condition (p > 0.05, Fig. 6E). In the presence 
of AMP-PCP or AMP-PNP, the remaining current after stimulation at high frequency displayed fast inactivation 
kinetics (p < 0.001, Fig. 6F). Because the depression of the current recovery may represent a spontaneous loss 
of channel activity (rundown) in the absence of intracellular ATP, we investigated the effect of AMP-PCP on 
the maintenance of Cav3.3 current. To this purpose, Cav3.3 currents were recorded during 30 minutes at a low 
frequency of stimulation (one stimulation each 180 s / 0.0055 Hz) in the presence of intracellular ATP or intracel-
lular AMP-PCP (Supplementary Fig. 3). At this low frequency of stimulation, there was no significant difference 
in Cav3.3 current rundown between control and AMP-PCP dialyzed cells (Supplementary Fig. 3A). On average 
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Figure 4. The activity-dependent Cav3.3 current inhibition is reduced in the presence of inorganic phosphate 
(Pi). (A,B) Examples of Cav3.3 currents elicited by the 1 Hz stimulation protocol during 40 s for the 1st and the 
3rd stimulation in cells dialyzed with 15 mM KCl, Ctrl (A), and in cells dialyzed with 10 mM KH2PO4, Pi (B). (C) 
Amplitude of the Cav3.3 current at the beginning (1 s) and after 40 s obtained at the 1st and the 3rd stimulation 
normalized to the initial current amplitude I (1 s 1st). (D) Inactivation kinetics of the Cav3.3 current at the 
beginning of the stimulation (1 s) and after 40 s stimulation obtained for the 1st and the 3rd stimulation. Asterisks 
indicate significant difference in the current amplitude (C) and inactivation kinetics (D), as compared to the 
initial current. In addition, variation in the current amplitude (C) and in inactivation kinetics (D) as function of 
the Pi treatment was statistically compared to the respective control condition, as indicated. The number of cells 
tested is indicated into brackets. (n.s.: non-significant).
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channel activity was 94 ± 6% (n = 6) and 89 ± 6% (n = 6) of the initial value after 30 minutes of dialysis with 3 mM 
intracellular ATP and with 3 mM intracellular AMP-PCP, respectively. Thus, the decrease in Cav3.3 current recov-
ery was not due to faster rundown of the current but to ATP dependency of current recovery from 1 Hz frequency 
stimulation. Accordingly, after 30 minutes of dialysis, the application of the 1 Hz stimulation protocol induced 
a decrease in the Cav3.3 current, which was irreversible in AMP-PCP dialyzed cells (p < 0.001, Supplementary 
Fig. 3A). Importantly, in the presence of intracellular BAPTA (instead EGTA), which prevents a localized increase 
in submembrane Ca2+ and the Ca2+-dependent inhibition of the Cav3.3 current15, we found that AMP-PCP did 
not produce current inhibition (p > 0.05, Fig. 6D–F) strongly indicating that the effect of non-hydrolysable ATP 
analogs relies on a Ca2+-dependent phosphorylation mechanism. It should be noted however, that NaN3 and 
non-hydrolysable ATP analogs may also interfere with mitochondrial function and could lead to an irreversible 
oxidative stress that may underlie the Cav3.3 current inhibition observed at fast frequency of stimulation. In 
order to investigate the potential role of the redox status in the current inhibition, the cells were dialyzed with an 
intracellular medium containing 1 mM dithiothreitol (DTT). After dialysis of DTT, the 1 Hz stimulation protocol 
induced inhibition of Cav3.3 current amplitude (~40%, p < 0.001, Supplementary Fig. 4B,C) that was associated 
with an acceleration of current inactivation kinetics (p < 0.001, Supplementary Fig. 4D). These effects were not 
different to those observed in the control condition (p > 0.05, Supplementary Fig. 4C,D). Similarly, current recov-
ery was unaffected (Supplementary Fig. 4C), suggesting that current modulation does not depend on the redox 
status of the Cav3.3 channel. We noted however that in the presence of DTT, the inactivation kinetics were slower 
at the beginning of the 1st stimulation as compared to the control condition (p < 0.05, n = 7) but this effect was not 
significant at the 3rd stimulation (Supplementary Fig. 4D).
Several pathways regulating Cav3 current were identified, including PKA34–36, PKC35,37,38, Rho-associated 
kinase39, phospholipase C (PLC40), and Gβγ36,41. We have tested whether these pathways could be implicated 
in the Cav3.3 modulation at high frequency of stimulation using dibutyryl-cAMP (db-cAMP, a PKA activator), 
phorbol myristate acetate (PMA, a PKC activator), chelerythrine and bisindolylmaleimide IX (BIM IX, both 
PKC inhibitors), fasudil (a Rho-associated kinase inhibitor), U73122 and edelfosine (both PLC inhibitors) and 
pertussis toxin (PTX) or expression of the βARK-Ct (both inhibiting Gβγ). In the presence of these compounds, 
the inhibition (~50%, p < 0.01, Supplementary Fig. 5A) of the Cav3.3 current was not different to that observed in 
the control condition (p > 0.05, Supplementary Fig. 5A). Importantly, these inhibitors did not modify the recov-
ery of the Cav3.3 current as compared to the control condition (p > 0.05, Supplementary Fig. 5B). Similarly, the 
inhibition of PI3K and PI4K with wortmannin or the inhibition of SERCA42 with cyclopiazonic acid (CPA) was 
without effect on both inhibition and recovery of the Cav3.3 current (p > 0.05 as compared to the control con-
dition, Supplementary Fig. 5A,B). Collectively, these results indicate that the Cav3.3 current modulation at high 
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Figure 5. The recovery of the Cav3.3 current is abolished in the presence of sodium azide. (A,B) Examples of 
Cav3.3 currents elicited by the 1 Hz stimulation protocol during 40 s for the 1st and the 3rd stimulation in the 
control condition, Ctrl (A), and in cells treated with sodium azide, NaN3 10 mM for 2 hours (B). (C) Amplitude 
of the Cav3.3 current at the beginning (1 s) and after 40 s obtained at the 1st and the 3rd stimulation normalized 
to the initial current amplitude I (1 s 1st). (D) Inactivation kinetics of the Cav3.3 current at the beginning of 
the stimulation (1 s) and after 40 s stimulation obtained for the 1st and the 3rd stimulation. Asterisks indicate 
significant difference in the current amplitude (C) and inactivation kinetics (D), as compared to the initial 
current. In addition, variation in the current amplitude (C) and in inactivation kinetics (D) as function of the 
NaN3 treatment was statistically compared to the respective control condition, as indicated. The number of cells 
tested is indicated into brackets. (n.s.: non-significant).
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frequency of stimulation involves a yet undescribed transduction pathway. We next tested several other kinases 
that could possibly modulate Cav3.3 current. We found that the presumed inhibition of PDK1 with OSU-03012, 
of AKT with AKT1/2 inhibitor, of PLK1/3 with GW843682X and BI 2536, of RSK with BI-D1870, of TAK1 with 
5Z-oxozeanol, of MNK1 with CGP57380, of PYK2/FAK with PF-431396, of SGK with GSK 650394, of GSK3 with 
CT 99021, of SRC with SU6656, of eEF2 kinase with A484954 and of MLCK with ML7, was without significant 
effects on both inhibition and recovery of the Cav3.3 current after the 1 Hz stimulation (p > 0.05 as compared to 
the values obtained in the control condition, Supplementary Fig. 6A,B).
We also investigated the ATP-dependency of the recombinant Cav3.1 current during fast stimulations (Fig. 7). 
In the presence of intracellular ATP, the Cav3.1 current decreased ~15% from its initial value during the 1 Hz 
frequency stimulation (p < 0.05; Fig. 7A,C) with an acceleration of its inactivation kinetics (p < 0.05; Fig. 7A,D). 
Importantly, the Cav3.1 current recovery was almost total when the stimulation ceased for 3 minutes, as illustrated 
at the beginning of the 3rd stimulation (Fig. 7A,C). In contrast, in AMP-PCP dialyzed cells, the Cav3.1 current 
inhibition became irreversible (p < 0.001 as compared to the control condition, Fig. 7B,C) and the remaining 
current displayed faster inactivation kinetics (p < 0.01, Fig. 7B,D). In addition, Cav3.1 current inhibition in the 
presence of AMP-PCP (~35% inhibition, p < 0.001) was more potent than that observed in ATP dialyzed cells for 
the 1st and the 3rd stimulation (p < 0.05, Fig. 7B,C), indicating that current inhibition is a very dynamic process. 
Importantly, in cells dialyzed with AMP-PCP + BAPTA, the stimulation at 1 Hz did not produce current inhibi-
tion and the inactivation kinetics remained unchanged (p > 0.05, Fig. 7C,D).
We have previously demonstrated that current inhibition relies mainly on a hyperpolarizing shift in the 
steady-state inactivation of the Cav3.3 current15. Therefore, we have measured the steady-state inactivation of the 
Cav3.3 current in the presence of non-hydrolysable ATP analogs. We found that, after the 3rd 1 Hz stimulation 
in the presence of AMP-PCP, there was a strong hyperpolarizing shift ~20 mV in the steady-state inactivation 
of the Cav3.3 current (Fig. 8A,B). In average, the V0.5 values of inactivation were −69.2 ± 0.6 mV in the control 
condition and −88.9 ± 1.1 mV in the presence of AMP-PCP (p < 0.001; Fig. 8C). Similar findings were obtained 
for AMP-PNP dialyzed cells and for NaN3 treated cells (Fig. 8C) since the V0.5 values of the steady-state inac-
tivation curves were −88.7 ± 2.2 mV (p < 0.001) and −88.2 ± 2.7 mV (p < 0.001), respectively. In contrast, we 
observed only a slight depolarizing shift in the presence of Pi (V0.5 was −64.5 ± 2.3 mV; Fig. 8C), which was not 
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Figure 6. Intracellular ATP is required for the recovery of the Cav3.3 current. (A–D) Examples of Cav3.3 
currents elicited by the 1 Hz stimulation protocol during 40 s for the 1st and the 3rd stimulation in cells dialyzed 
with 3 mM ATP, Ctrl (A), in cells dialyzed with 3 mM AMP-PCP (B), in cells dialyzed with 3 mM AMP-PNP 
(C) and in cells dialyzed with 3 mM AMP-PCP and 30 mM BAPTA (D). (E) Amplitude of the Cav3.3 current 
at the beginning (1 s) and after 40 s obtained at the 1st and the 3rd stimulation normalized to the initial current 
amplitude I (1 s 1st). (F) Inactivation kinetics of the Cav3.3 current at the beginning of the stimulation (1 s) and 
after 40 s stimulation obtained for the 1st and the 3rd stimulation. Asterisks indicate significant difference in the 
current amplitude (E) and inactivation kinetics (F), as compared to the initial current. In addition, variation in 
the current amplitude (E) and in inactivation kinetics (F) as function of the treatment was statistically compared 
to the respective control condition, as indicated. The hash signs indicate statistical difference between AMP-
PCP and AMP-PCP + BAPTA. The number of cells tested is indicated into brackets. (n.s.: non-significant).
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significant. Importantly, we found that in the presence of intracellular BAPTA, AMP-PCP produced no signif-
icant shift in the steady-state inactivation curve of the Cav3.3 current (p > 0.05, Fig. 8C). Similar findings were 
obtained for the recombinant Cav3.1 current since the steady-state inactivation was significantly shifted towards 
negative potentials by ~8 mV in the presence of AMP-PCP and this shift was abolished in the presence of BAPTA 
(Fig. 8D). In average we found that the V0.5 values of the steady-state inactivation curves for the Cav3.1 current 
were −80.6 ± 1.3 mV in the control condition, −88.3 ± 1.7 mV for the AMP-PCP dialyzed cells (p < 0.01) and 
−75.1 ± 0.4 mV for the cells dialyzed with AMP-PCP combined with BAPTA (p < 0.05 as compared to the control 
condition, and p < 0.0001 as compared to the AMP-PCP dialyzed cells).
We next explored whether a similar regulation of the native T-type current may occur in thalamic neurons. 
The effects of intracellular AMP-PCP and BAPTA were investigated in acute brain slices focusing on the T-type 
current expressed in the central medial nucleus (CeM) neurons of the thalamus, that are enriched in Cav3.1 cur-
rents27. In the presence of AMP-PCP, the T-type current amplitude in CeM neurons decreased during stimulation 
at the frequency of 1 Hz (Fig. 9A,B) and reached ~15% inhibition after 40 s of stimulation (p < 0.01, Fig. 9B,C). 
This decrease in the T-type current amplitude was prevented by the substitution of intracellular EGTA with 
BAPTA suggesting the role of local increase in intracellular Ca2+ concentration in current inhibition (Fig. 9B,C). 
As observed for recombinant T-type channels, steady-state inactivation of the T-type current in CeM neurons 
was shifted towards the negative potentials in the presence of AMP-PCP (Fig. 9D,E). This shift in the steady-state 
inactivation was similar to the one observed when ATP was omitted in the intracellular solution (Fig. 9E), sug-
gesting that the ATP effect relies mainly on a putative phosphorylation mechanism. In average, the V0.5 val-
ues of the steady-state inactivation curves were −75.4 ± 1.6 mV in the control condition with intracellular ATP, 
−82.3 ± 1.9 mV for the cells dialyzed with an ATP-free solution (p < 0.05) and −83.7 ± 1.65 mV for the cells 
dialyzed with AMP-PCP (p < 0.01, Fig. 9E). Importantly, the shift in the steady-state inactivation of the T-type 
current did not occur when the intracellular solution contained AMP-PCP in the presence of BAPTA (p > 0.05 
as compared to the control conditions, Fig. 9E). Overall, these data strongly suggest that the availability of both 
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Figure 7. The recovery of the Cav3.1 current after its inhibition by the 1 Hz stimulation required intracellular 
ATP. (A,B) Typical examples of Cav3.1 currents elicited by the 1 Hz stimulation protocol during 40 s for the 1st 
and the 3rd stimulation in cells dialyzed with 3 mM ATP, Ctrl (A) and in cells dialyzed with 3 mM AMP-PCP 
(B). The Cav3.1 currents were elicited using a 1 Hz test pulse stimulation at −30 mV (180 ms duration) from 
a HP of −100 mV. (C) Amplitude of the Cav3.1 current at the beginning (1 s) and after 40 s obtained at the 1st 
and the 3rd stimulation normalized to the initial current amplitude I (1 s 1st). (D) Inactivation kinetics of the 
Cav3.1 current at the beginning of the stimulation (1 s) and after 40 s stimulation obtained for the 1st and the 3rd 
stimulation. Asterisks indicate significant difference in the current amplitude (C) and inactivation kinetics (D), 
as compared to the initial current. Variation in the current amplitude (C) and in inactivation kinetics (D) as 
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recombinant and native T-type current depends on a phosphorylation process, which is regulated by the local 
concentration of intracellular calcium (see schematic representation in Supplementary Fig. 7).
Discussion
Recently, we demonstrated that the availability of the Cav3 channels can be dynamically tuned by changes in the 
intracellular Ca2+ concentration at the vicinity of these channels15. Here we describe that this Ca2+-induced mod-
ulation of the Cav3 current likely relies on a phosphorylation mechanism. This modulation occurs for both Cav3.3 
and Cav3.1 recombinant channels, as well as for native neuronal T-type channels. Importantly, this modulation 
of T-type channels by intracellular Ca2+ is novel among the Ca2+ channel family as it involves a phosphorylation 
process not related to calcineurin, endocytosis and calmodulin-dependent pathways.
The regulation of the high-voltage-activated Cav1 and Cav2 Ca2+ channels by a rise in intracellular Ca2+ has 
been extensively studied and serves as a reference13,14,19–21,23–26. For the L-type / Cav1.2 channel a rise in intracel-
lular Ca2+ induces complex effects depending on the amount of the calcium ions. Ca2+ entry via L-type channels 
first induces a Ca2+-dependent inactivation (CDI) characterized by an acceleration of the inactivation kinetics 
of the L-type current that is followed, if the stimulation persists, by a decrease/rundown of the current. It was 
established that both CDI14,19–21,24 and rundown23,24 of the L-type current are dependent on calmodulin activity. 
Clearly, the modulation of the Cav3.3 current described here is independent of the calmodulin-dependent path-
way, contrasting with the well-established Ca2+-dependent mechanisms regulating the L-type channels.
Importantly recent studies have revealed that calmodulin interacts with Cav3 channels16–18. We have pre-
viously reported that the steady-state inactivation of the Cav3.2 current was negatively shifted ~5 mV towards 
negative potentials in the presence of the CaM1234 mutant that does not bind Ca2+17, and we find here that this is 
also the case with the Cav3.3 current. However, in the presence of this mutant, the inhibition of Cav3.3 current at 
a high frequency of stimulation is preserved as well as the current recovery after the stopping of the stimulation. 
Similar findings were obtained using a CaMKII peptide that binds CaM and inhibits its function. In contrast with 
our results, another study found that in the presence of 1 µM intracellular Ca2+, the steady-state inactivation of 
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the Cav3.3 current is shifted ~6 mV towards negative potentials and this effect is occluded by the over-expression 
of the CaM1234 mutant18. This suggest that a prolonged and global increase in intracellular Ca2+18 may lead to 
the activation of distinct intracellular pathways, as compared to a transient and local increase in intracellular 
Ca2+, which occurs here during the fast stimulation of the Cav3.3 current. The Ca2+/CaM-activated phosphatase 
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Figure 9. The native T-type current from neurons of rat central medial (CeM) nucleus is regulated by an 
interplay between a rise in intracellular calcium and a phosphorylation mechanism. (A) Typical T-type current 
elicited by stimulation at −30 mV applied at a frequency of 1 Hz from a holding potential of −90 mV obtained 
from CeM neurons dialyzed with either AMP-PCP or AMP-PCP combined with BAPTA. (B) Normalized 
current amplitude from 1 to 40 s. (C) Average normalized current amplitude recorded at 1 s and at 40 s. Asterisks 
indicate significant difference in the current amplitude at 40 s as compared to the current amplitude at 1 s. The 
hash signs indicate statistical difference between AMP-PCP and AMP-PCP + BAPTA. (D) Representative 
T-type current recorded at −50 mV from holding potentials ranging from −120 to −50 mV (5 mV increment, 
3.6 s duration). CeM neurons were dialyzed with either ATP (control condition) or AMP-PCP. The red 
trace indicates the half-inactivation potential. (E) Average steady-state inactivation curves obtained from 
experiments presented in (D) for neurons dialyzed with ATP (control), AMP-PCP, AMP-PCP combined with 
BAPTA, and in absence of ATP (ATP-free).
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calcineurin was also shown to interact with Cav3.2 channels and Ca2+ entry via these channels induces the 
calcineurin-dependent activation of the transcription factor NFAT43–45. In addition, both L-type current decrease 
during fast stimulation and CDI were prevented after calcineurin inhibition23,24, suggesting that calcineurin may 
mediate inhibition of the Cav3.3 current. However, prolonged treatment with several calcineurin inhibitors was 
without effect on Cav3.3 current modulation, confirming a study on T-type currents in sensory neurons46. It was 
also demonstrated that Ca2+ entry via Cav3 channels can promote a Ca2+-dependent CaM dissociation from the 
channels leading to CaMKII activation, which is blocked using the CaMKII inhibitory peptide AIP16. In addi-
tion, in the presence of micromolar concentrations of intracellular Ca2+, CaMKII can regulate Cav3.2 current by 
phosphorylation of serine residues 1198 and 1153 in the channel’s 2–3 intracellular loop47–49. This regulation is 
abolished in the presence of the AIP peptide or by substitution of intracellular ATP by AMP-PNP47. However, 
this latter regulation of the Cav3.2 current is clearly different from the one described here for the Cav3.3 current, 
since Ca2+ / CaMKII activation promotes an increase (but not inhibition) of the Cav3.2 current by promoting a 
negative shift in the activation curve without any effect on the steady-state inactivation. In addition, this Cav3.2 
regulation involves CaMKIIγc, which is not expressed in HEK-293 cells47. Accordingly, we found that the dialysis 
of the AIP peptide had no effect on both inhibition and recovery of the Cav3.3 current. Therefore, although CaM/
Calcineurin/CaMKII pathways interact with Cav3 channels, our data strongly support the idea that the modula-
tion of the Cav3.3 current at a high frequency of stimulation requires additional Ca2+-dependent mechanisms.
Endocytosis could be another mechanism leading to the decrease of the Cav3.3 current. Indeed, for the L-type 
channels, a prolonged current stimulation or activation of the ionotropic NMDA receptors induces the internali-
zation of the channels and potentially their degradation in lysosomes or their recycling to the plasma membrane 
depending of the amount and the duration of the Ca2+ entry21,25,26. These studies have highlighted the crucial 
role of dynamin 1, a GTPase required for the formation of endocytic vesicles from the plasma membrane28, in 
the early steps of this process21,25,26. In the presence of a dominant negative mutant of dynamin 1 (Dyn 1 K44A), 
which abolishes the endocytosis of the L-type channel25, the inhibition of the Cav3.3 current during 1 Hz stimula-
tion is not affected as well as its recovery when the stimulation ceases. In addition, a role of lysosomal degradation 
is unlikely since Cav3.3 current inhibition and its recovery are preserved after treatment of the cells with bafilo-
mycin, which prevents degradation of the L-type channel26. Therefore, although the regulation by intracellular 
Ca2+ of L- and T-type channels share similar features, the mechanism underlying the Ca2+ dependent inhibition 
of T-type channels during fast stimulation is clearly different from the one described for L-type channels.
We found that the Cav3.3 current modulation observed at a high frequency of stimulation likely relies on a 
phosphorylation mechanism (see schematic representation in Supplementary Fig. 7). Accordingly, the inhibition 
of the Cav3.3 current during fast stimulation is decreased in a presence of intracellular Pi, which is a competi-
tive inhibitor of phosphatase activities30,31. Conversely, sodium azide, a pharmacological agent that promotes the 
depletion of intracellular ATP by the inhibition of cytochrome oxidase33, the final enzyme in the mitochondrial 
electron transport chain, abolishes the recovery of the Cav3.3 current after its inhibition induced by the fast stim-
ulation. Therefore, we hypothesized that ATP is necessary in the recovery process. We used non-hydrolysable 
ATP analogs, AMP-PNP and AMP-PCP, which are competitive inhibitors of reactions requiring hydrolysable 
ATP50. The substitution of intracellular ATP with AMP-PNP or AMP-PCP, abolishes the recovery of the Cav3.3 
current, indicating the crucial role of a phosphorylation-dependent mechanism in the Ca2+-induced inhibition 
of the Cav3.3 current. This depression of recovery in AMP-PCP dialyzed cells might be a consequence of a run-
down of the Cav3.3 current during the experiment leading to an apparent inhibition of recovery after fast stim-
ulation. However, we found a similar rundown of the Cav3.3 current when stimulated at a low frequency in ATP 
and in AMP-PCP dialyzed cells, indicating that the effect of AMP-PCP depends on the previous inhibition of 
the Cav3.3 current by a fast stimulation. Accordingly, in the presence of intracellular BAPTA, which prevents a 
local submembrane rise in Ca2+ 51–53, AMP-PCP did not produce current inhibition indicating that the effect of 
non-hydrolysable ATP analogs relies on a Ca2+-dependent mechanism.
We used different pharmacological antagonists to examine the potential involvement of various intracellular 
pathways underlying the Cav3.3 current modulation. Interestingly, the recovery of the Cav3.3 current after fast 
stimulation does not depend of the previously identified kinases that modulated the Cav3 current, including PKA, 
PKC and Rho-associated kinase34–37,39. The recovery of the Cav3.3 current is also resistant to the inhibition of 
PI3K / PI4K, PDK1, AKT, PLK1/3, RSK, TAK1, PYK2/FAK, SGK, GSK3, SRC, eEF2 or MLCK. Therefore, further 
extensive biochemical and electrophysiological studies are needed to identify the precise signaling pathways that 
modulate the Cav3.3 current.
We have previously demonstrated that a rise in submembrane Ca2+ ions induces a hyperpolarizing shift in the 
steady-state inactivation of the Cav3.3 current, a regulation that is also found for the Cav3.1 current15. Here we 
show that sodium azide, AMP-PNP and AMP-PCP treatment, induced a large ~20 mV hyperpolarizing shift in 
the steady-state inactivation of the Cav3.3 current, confirming a common mechanism. Accordingly, AMP-PCP 
has no effect on the steady-state inactivation of the Cav3.3 current in cells dialyzed with BAPTA. Regarding the 
Cav3.1 current, its inhibition during stimulation at a high frequency in the presence of intracellular ATP is modest 
(~15%) compared to Cav3.3, most likely due to its rapid inactivation kinetics leading to a moderate increase in 
intracellular Ca2+ 54–56. As observed for the Cav3.3 current, the inhibition of the Cav3.1 current is irreversible in 
the presence of intracellular AMP-PCP whereas the inhibition is prevented in the presence of BAPTA. In addi-
tion, the steady-state inactivation curve of the Cav3.1 current is shifted by ~8 mV towards negative potentials in 
the presence of AMP-PCP. Therefore, our data reveal that the T-type channel modulation by intracellular Ca2+ 
has unusual features among the Ca2+ channel family both in its transduction and its underlying biophysical 
mechanisms.
Importantly, we found that the native Cav3.1 T-type current recorded in neurons of the central medial nucleus 
(CeM) of the thalamus27, is subject to a similar Ca2+-dependent regulation. When stimulated at a frequency of 1 Hz, 
the T-type current in CeM neurons decreases ~15% in the presence of AMP-PCP and this effect is abolished in 
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the presence of intracellular BAPTA. As observed for recombinant channels, this inhibition relies on a shift of the 
steady-state inactivation since the native T-type current displays a ~8 mV negative shift in the steady-state inacti-
vation curve in the presence of AMP-PCP, which is abolished in the presence of BAPTA. This shift is similar to the 
one observed in cells dialyzed with an ATP-free solution, indicating that ATP effect relies on a phosphorylation 
mechanism. Interestingly, it was previously reported in thalamocortical neurons of the ventrobasal nucleus that the 
steady-state inactivation of the T-type current progressively shifts towards negative potentials during the dialysis 
of an ATP-free solution, indicating that the ATP-dependency of the T-type channel availability is not restricted to 
CeM neurons57. Overall, our study demonstrates that the availability of both recombinant and native T-type chan-
nels depends on a phosphorylation process regulated by the local intracellular Ca2+ concentration (Supplementary 
Fig. 7). This Ca2+-dependent inhibition of T-type channel would provide an important feedback mechanism during 
sustained neuronal activities to limit intracellular Ca2+ overload. It should be noted however that although our study 
highlights the role of a putative phosphorylation mechanism, whether the Cav3 channel is directly phosphorylated 
or modulated via an intermediate protein remains an open question. Future molecular and biochemical studies will 
be necessary to clarify this important aspect and identify the key residues implicated in the Cav3 current regulation.
By demonstrating that the availability of the T-type channels critically depends on an interplay between Ca2+ 
entry and the cellular phosphorylation status, we document a novel and important mechanism that tightly and 
dynamically controls T-type channel activity. Considering that T-type channels are widely expressed in the cen-
tral nervous system where they contribute to the rebound burst firing activities6,7, and that an alteration in their 
activity is implicated in several neuronal disorders, including epilepsy, schizophrenia, autism, chronic pain and 
cerebellar ataxia2,8,10–12, this phosphorylation-dependent Ca2+-sensitive mechanism might be crucial to accurately 
balance the electrical and Ca2+ signaling of T-type channels both in their normal physiological responses and in 
disease states involving these channels.
Methods
Cell culture, transfection and electrophysiological recordings in tsA-201 cells. Cell culture and 
transfection of tsA-201 cells were performed as described previously15. Briefly, transfections were performed 
using jet-PEI (Ozyme, France) with a DNA mix (1.5 µg total) containing 0.5% of a GFP encoding plasmid and 
99.5% of the pcDNA3.1 plasmid constructs that code for the human Cav3.1 (isoform Cav3.1a, Genbank accession 
number AF126966.158) and human Cav3.3 (isoform LT9, Genbank accession number AF393329.159) channels. In 
some experiments, 1.5 µg of the plasmids that code for Dynamin 1, Dynamin 1 K44A, AP-2, CaM1234 or βARK-Ct 
was added to the DNA mix. Two days after transfection, tsA-201 cells were dissociated with Versene (Invitrogen, 
Fisher Scientific, France) and plated at low density for electrophysiological recordings, as described previously15. 
Macroscopic currents were recorded at room temperature using an internal solution containing (in mM): 140 CsCl, 
10 EGTA, 10 HEPES, 3 Mg-ATP, 0.6 GTPNa, and 3 CaCl2 (pH adjusted to 7.25 with KOH, ~315 mOsm, ~100 nM 
free Ca2+ using the MaxChelator software, http://maxchelator.stanford.edu/) and an extracellular solution contain-
ing (in mM): 135 NaCl, 20 TEACl, 2 CaCl2, 1 MgCl2, and 10 HEPES (pH adjusted to 7.25 with KOH, ~330 mOsm).
In vitro brain slice preparation from juvenile rats. Experimental procedures with animals were per-
formed as described previously27 according to the protocol #B-111616 (02) 1E approved by the Animal Care and 
Use Committee at the University of Colorado Anschutz Medical Campus. Treatments of rats adhered to guide-
lines set forth in the NIH Guide for the Care and Use of Laboratory Animals. All efforts were made to minimize 
animal suffering and to use only the number of animals necessary to produce reliable scientific data. Experiments 
were performed on male and female Sprague-Dawley rats (P23-P26) obtained from Envigo (Indianapolis, IN, 
USA). Brain slice preparation was obtained as described previously27. Brain slices were immediately incubated for 
30 min in the following solution (in mM): 124 NaCl, 10 D-glucose, 26 NaHCO3, 1.25 NaH2PO4, 4 KCl, 2 CaCl2, 
2 MgCl2 at 37 °C before use in electrophysiology experiments, which were done at room temperature. During 
incubation, slices were constantly perfused with a gas mixture of 95 vol% O2 and 5 vol% CO2.
Electrophysiological recordings in CeM neurons. Whole-cell recordings were performed in CeM neu-
rons, as described previously27. The external solution contained (in mM): 125 NaCl, 25 D-glucose, 25 NaHCO3, 1.25 
NaH2PO4, 2.5 KCl, 1 MgCl2, 2 CaCl2. The voltage-dependent sodium current blocker tetrodotoxin (TTX; 1 μM) was 
added to the extracellular medium. The internal solution for voltage-clamp experiments with Cesium (Cs) containing 
ATP solution consisted of the following (in mM): 110 Cs-methane sulfonate, 14 phosphocreatine, 10 HEPES, 9 EGTA, 
5 Mg-ATP, and 0.3 Tris-GTP, pH adjusted to 7.15 to 7.20 with CsOH (~300 mOsm). The ATP-free internal consisted 
of the following (in mM): 110 Cs methane sulfonate, 10 HEPES, 9 EGTA. The AMP-PCP based internals had 3 mM 
AMP-PCP instead of Mg-ATP. AMP-PCP solution with BAPTA had 30 mM BAPTA as an alternative to EGTA.
Data analysis. Current traces were analyzed using pCLAMP9 (Molecular Devices) and GraphPad Prism 
(GraphPad) softwares. Steady-state inactivation curves were fitted using the Boltzmann equation where I/I 
max = 1/(1 + exp((Vm−V0.5)/slope factor)). Results are presented as the mean ± SEM, and n is the number of 
cells. Statistical analysis were performed with two-way ANOVA combined with a Tukey post-test for multiple 
comparisons, excepted in Fig. 1, for which a one-way ANOVA combined with a Tukey post-test for multiple 
comparisons was used (*p < 0.05, **p < 0.01, ***p < 0.001).
Chemical reagents. The CaMKII 290–309 peptide, the autocamtide-2-related inhibitory peptide (AIP) and 
the calcineurin inhibitory peptide (CIP) were obtained from Enzo life science (France). STO-609, BIM IX, BI 
2536, BI-D1870, SU6656 and A484954 were obtained from Cayman Chemical (Interchim Inc., France). OSU-
03012, AKT1/2 I, GW843682X, 5Z-oxozeaenol, CGP 57380, PF-431396, GSK 650394, CT 99021 and ML-7 
were purchased from Tocris (R&D Systems Europe, France). All others compounds were obtained from Sigma 
(France). The control experiments were performed using the corresponding solvent.
13Scientific RepoRtS |         (2019) 9:15642  | https://doi.org/10.1038/s41598-019-52194-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
Received: 4 February 2019; Accepted: 13 October 2019;
Published: xx xx xxxx
References
 1. Zamponi, G. W., Striessnig, J., Koschak, A. & Dolphin, A. C. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium 
Channels and Their Future Therapeutic Potential. Pharmacol Rev 67, 821–870, https://doi.org/10.1124/pr.114.009654 (2015).
 2. Zamponi, G. W. Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nat Rev Drug Discov 15, 19–34, 
https://doi.org/10.1038/nrd.2015.5 (2016).
 3. Eckert, R. & Chad, J. E. Inactivation of Ca channels. Prog Biophys Mol Biol 44, 215–267 (1984).
 4. Ben-Johny, M. & Yue, D. T. Calmodulin regulation (calmodulation) of voltage-gated calcium channels. J Gen Physiol 143, 679–692, 
https://doi.org/10.1085/jgp.201311153 (2014).
 5. Ertel, E. A. et al. Nomenclature of voltage-gated calcium channels. Neuron 25, 533–535 (2000).
 6. Huguenard, J. R. Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol 58, 329–348, https://doi.
org/10.1146/annurev.ph.58.030196.001553 (1996).
 7. Perez-Reyes, E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 83, 117–161, https://doi.
org/10.1152/physrev.00018.2002 (2003).
 8. Beenhakker, M. P. & Huguenard, J. R. Neurons that fire together also conspire together: is normal sleep circuitry hijacked to generate 
epilepsy? Neuron 62, 612–632, https://doi.org/10.1016/j.neuron.2009.05.015 (2009).
 9. Crunelli, V., David, F., Leresche, N. & Lambert, R. C. Role for T-type Ca2+ channels in sleep waves. Pflugers Arch 466, 735–745, 
https://doi.org/10.1007/s00424-014-1477-3 (2014).
 10. Todorovic, S. M. & Jevtovic-Todorovic, V. T-type voltage-gated calcium channels as targets for the development of novel pain 
therapies. Br J Pharmacol 163, 484–495, https://doi.org/10.1111/j.1476-5381.2011.01256.x (2011).
 11. Andrade, A. et al. A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity. Sci Rep 6, 34233, https://doi.
org/10.1038/srep34233 (2016).
 12. Chemin, J. et al. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the 
CACNA1G calcium channel gene. Brain 141, 1998–2013, https://doi.org/10.1093/brain/awy145 (2018).
 13. Liang, H. et al. Unified mechanisms of Ca2+ regulation across the Ca2+ channel family. Neuron 39, 951–960 (2003).
 14. Dick, I. E. et al. A modular switch for spatial Ca2+ selectivity in the calmodulin regulation of CaV channels. Nature 451, 830–834, 
https://doi.org/10.1038/nature06529 (2008).
 15. Cazade, M., Bidaud, I., Lory, P. & Chemin, J. Activity-dependent regulation of T-type calcium channels by submembrane calcium 
ions. Elife 6, https://doi.org/10.7554/eLife.22331 (2017).
 16. Asmara, H. et al. A T-type channel-calmodulin complex triggers alphaCaMKII activation. Mol Brain 10, 37, https://doi.org/10.1186/
s13041-017-0317-8 (2017).
 17. Chemin, J. et al. Calmodulin regulates Cav3 T-type channels at their gating brake. J Biol Chem, https://doi.org/10.1074/jbc.
M117.807925 (2017).
 18. Lee, N. et al. Ca2+ Regulation of Cav3.3 T-type Ca2+ Channel Is Mediated by Calmodulin. Mol Pharmacol 92, 347–357, https://doi.
org/10.1124/mol.117.108530 (2017).
 19. Peterson, B. Z., DeMaria, C. D., Adelman, J. P. & Yue, D. T. Calmodulin is the Ca2+ sensor for Ca2+ -dependent inactivation of L-type 
calcium channels. Neuron 22, 549–558 (1999).
 20. Zuhlke, R. D., Pitt, G. S., Deisseroth, K., Tsien, R. W. & Reuter, H. Calmodulin supports both inactivation and facilitation of L-type 
calcium channels. Nature 399, 159–162, https://doi.org/10.1038/20200 (1999).
 21. Hall, D. D. et al. Competition between alpha-actinin and Ca(2)(+)-calmodulin controls surface retention of the L-type Ca(2)(+) 
channel Ca(V)1.2. Neuron 78, 483–497, https://doi.org/10.1016/j.neuron.2013.02.032 (2013).
 22. Ben-Johny, M. et al. Conservation of Ca2+/calmodulin regulation across Na and Ca2+ channels. Cell 157, 1657–1670, https://doi.
org/10.1016/j.cell.2014.04.035 (2014).
 23. Oliveria, S. F., Dell’Acqua, M. L. & Sather, W. A. AKAP79/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel 
activity and nuclear signaling. Neuron 55, 261–275, https://doi.org/10.1016/j.neuron.2007.06.032 (2007).
 24. Oliveria, S. F., Dittmer, P. J., Youn, D. H., Dell’Acqua, M. L. & Sather, W. A. Localized calcineurin confers Ca2+-dependent inactivation 
on neuronal L-type Ca2+ channels. J Neurosci 32, 15328–15337, https://doi.org/10.1523/JNEUROSCI.2302-12.2012 (2012).
 25. Green, E. M., Barrett, C. F., Bultynck, G., Shamah, S. M. & Dolmetsch, R. E. The tumor suppressor eIF3e mediates calcium-dependent 
internalization of the L-type calcium channel CaV1.2. Neuron 55, 615–632, https://doi.org/10.1016/j.neuron.2007.07.024 (2007).
 26. Tsuruta, F., Green, E. M., Rousset, M. & Dolmetsch, R. E. PIKfyve regulates CaV1.2 degradation and prevents excitotoxic cell death. 
J Cell Biol 187, 279–294, https://doi.org/10.1083/jcb.200903028 (2009).
 27. Stamenic, T. T. & Todorovic, S. M. Cytosolic ATP Relieves Voltage-Dependent Inactivation of T-Type Calcium Channels and Facilitates 
Excitability of Neurons in the Rat Central Medial Thalamus. eNeuro 5, https://doi.org/10.1523/ENEURO.0016-18.2018 (2018).
 28. Praefcke, G. J. & McMahon, H. T. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol 
Cell Biol 5, 133–147, https://doi.org/10.1038/nrm1313 (2004).
 29. Traub, L. M. Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev Mol Cell Biol 10, 583–596, https://doi.
org/10.1038/nrm2751 (2009).
 30. Taga, E. M. & Van Etten, R. L. Human liver acid phosphatases: purification and properties of a low-molecular-weight isoenzyme. 
Arch Biochem Biophys 214, 505–515 (1982).
 31. Kim, E. E. & Wyckoff, H. W. Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. J Mol 
Biol 218, 449–464 (1991).
 32. Blesneac, I. et al. Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties. Proc Natl Acad Sci 
USA 112, 13705–13710, https://doi.org/10.1073/pnas.1511740112 (2015).
 33. Tsubaki, M. Fourier-transform infrared study of azide binding to the Fea3-CuB binuclear site of bovine heart cytochrome c oxidase: 
new evidence for a redox-linked conformational change at the binuclear site. Biochemistry 32, 174–182 (1993).
 34. Kim, J. A. et al. Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A. J Pharmacol Exp 
Ther 318, 230–237, https://doi.org/10.1124/jpet.106.101402 (2006).
 35. Chemin, J. et al. Temperature-dependent modulation of CaV3 T-type calcium channels by protein kinases C and A in mammalian 
cells. J Biol Chem 282, 32710–32718, https://doi.org/10.1074/jbc.M702746200 (2007).
 36. Hu, C., Depuy, S. D., Yao, J., McIntire, W. E. & Barrett, P. Q. Protein kinase A activity controls the regulation of T-type CaV3.2 
channels by Gbetagamma dimers. J Biol Chem 284, 7465–7473, https://doi.org/10.1074/jbc.M808049200 (2009).
 37. Park, J. Y. et al. Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density. J 
Physiol 577, 513–523, https://doi.org/10.1113/jphysiol.2006.117440 (2006).
 38. Joksovic, P. M. et al. Mechanisms of inhibition of T-type calcium current in the reticular thalamic neurons by 1-octanol: implication 
of the protein kinase C pathway. Mol Pharmacol 77, 87–94, https://doi.org/10.1124/mol.109.059931 (2010).
 39. Iftinca, M. et al. Regulation of T-type calcium channels by Rho-associated kinase. Nat Neurosci 10, 854–860, https://doi.org/10.1038/
nn1921 (2007).
1 4Scientific RepoRtS |         (2019) 9:15642  | https://doi.org/10.1038/s41598-019-52194-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
 40. Hildebrand, M. E. et al. Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine 
receptors. J Biol Chem 282, 21043–21055, https://doi.org/10.1074/jbc.M611809200 (2007).
 41. Wolfe, J. T., Wang, H., Howard, J., Garrison, J. C. & Barrett, P. Q. T-type calcium channel regulation by specific G-protein betagamma 
subunits. Nature 424, 209–213, https://doi.org/10.1038/nature01772 (2003).
 42. Cueni, L. et al. T-type Ca2+ channels, SK2 channels and SERCAs gate sleep-related oscillations in thalamic dendrites. Nat Neurosci 
11, 683–692, https://doi.org/10.1038/nn.2124 (2008).
 43. Chiang, C. S. et al. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ 
Res 104, 522–530, https://doi.org/10.1161/CIRCRESAHA.108.184051 (2009).
 44. Huang, C. H., Chen, Y. C. & Chen, C. C. Physical interaction between calcineurin and Cav3.2 T-type Ca2+ channel modulates their 
functions. FEBS Lett 587, 1723–1730, https://doi.org/10.1016/j.febslet.2013.04.040 (2013).
 45. Lin, S. S. et al. Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage. Proc Natl 
Acad Sci USA 111, E1990–1998, https://doi.org/10.1073/pnas.1323112111 (2014).
 46. Comunanza, V., Carbone, E., Marcantoni, A., Sher, E. & Ursu, D. Calcium-dependent inhibition of T-type calcium channels by 
TRPV1 activation in rat sensory neurons. Pflugers Arch 462, 709–722, https://doi.org/10.1007/s00424-011-1023-5 (2011).
 47. Wolfe, J. T., Wang, H., Perez-Reyes, E. & Barrett, P. Q. Stimulation of recombinant Ca(v)3.2, T-type, Ca(2+) channel currents by 
CaMKIIgamma(C). J Physiol 538, 343–355 (2002).
 48. Welsby, P. J. et al. A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II. J 
Neurosci 23, 10116–10121 (2003).
 49. Yao, J. et al. Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase 
II. J Clin Invest 116, 2403–2412, https://doi.org/10.1172/JCI27918 (2006).
 50. Suh, B. C. & Hille, B. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate 
synthesis. Neuron 35, 507–520 (2002).
 51. Marty, A. & Neher, E. Potassium channels in cultured bovine adrenal chromaffin cells. J Physiol 367, 117–141 (1985).
 52. Roberts, W. M. Spatial calcium buffering in saccular hair cells. Nature 363, 74–76, https://doi.org/10.1038/363074a0 (1993).
 53. Deisseroth, K., Bito, H. & Tsien, R. W. Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple 
forms of hippocampal synaptic plasticity. Neuron 16, 89–101 (1996).
 54. Klockner, U. et al. Comparison of the Ca2+ currents induced by expression of three cloned alpha1 subunits, alpha1G, alpha1H and 
alpha1I, of low-voltage-activated T-type Ca2+ channels. Eur J Neurosci 11, 4171–4178 (1999).
 55. Kozlov, A. S. et al. Distinct kinetics of cloned T-type Ca2+ channels lead to differential Ca2+ entry and frequency-dependence during 
mock action potentials. Eur J Neurosci 11, 4149–4158 (1999).
 56. Chemin, J. et al. Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal 
excitability. J Physiol 540, 3–14 (2002).
 57. Leresche, N., Hering, J. & Lambert, R. C. Paradoxical potentiation of neuronal T-type Ca2+ current by ATP at resting membrane 
potential. J Neurosci 24, 5592–5602, https://doi.org/10.1523/JNEUROSCI.1038-04.2004 (2004).
 58. Monteil, A. et al. Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels. J Biol 
Chem 275, 6090–6100, https://doi.org/10.1074/jbc.275.9.6090 (2000).
 59. Gomora, J. C., Murbartian, J., Arias, J. M., Lee, J. H. & Perez-Reyes, E. Cloning and expression of the human T-type channel 
Ca(v)3.3: insights into prepulse facilitation. Biophys J 83, 229–241 (2002).
Acknowledgements
We are grateful to Drs R.C. Lambert, A. François and P.F. Mery for helpful discussions. We thank Dr. T. Moore-
Morris for critical reading of the manuscript. This work was support in part by the Centre National de la 
Recherche Scientifique (CNRS), by ANR-11-LABX-0015 (to PL) and by NIH grant GM102525 and March of 
Dimes Research Award 0529 (to SMT).
Author contributions
J.C., conceptualization, investigation, analysis, supervision, writing-original draft; T.T.S., M.C., J.L., I.B.; 
investigation, analysis; S.M.T., supervision, revised the manuscript; P.L., supervision, revised the manuscript.
competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41598-019-52194-6.
Correspondence and requests for materials should be addressed to J.C.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
A novel phospho-modulatory mechanism contributes to the calcium-dependent 
regulation of T-type Ca2+ channels. 
 
Jean Chemin 1,2,*, Tamara Timic Stamenic 3, Magalie Cazade 1,2, Jodie Llinares 1,2, Iulia 
Blesneac 1,2, Slobodan M. Todorovic 3, Philippe Lory 1,2. 
 
1 IGF, CNRS, INSERM, University of Montpellier, Montpellier, France; 2 LabEx ’Ion 
Channel Science and Therapeutics’, 34094 Montpellier, France. 
3 Department of Anesthesiology, University of Colorado, Aurora, CO 80045. 
 
Running title: Ca2+ / Phospho-regulation of T-channels 
 
* Correspondence to Jean Chemin: jean.chemin@igf.cnrs.fr. 
 
 
 
Supplementary Information 
 
Supplementary Figure Legends 
Supplementary Figure 1. Endocytosis and lysosomal degradation are not involved in the 
activity-dependent Cav3.3 current inhibition. 
(A-D) Examples of Cav3.3 currents elicited by the 1 Hz stimulation protocol during 40 s for the 
1st and the 3rd stimulation for cells expressing Dynamin WT (A), Dynamin K44A (B), AP-2 
(C), and for cells treated with 100 nM bafilomycin for 4-5 hours (D). (E) Amplitude of the 
Cav3.3 current at the beginning (1 s) and after 40 s obtained at the 1
st and the 3rd stimulation 
normalized to the initial current amplitude I (1s 1st). Asterisks indicate significant difference in 
the current amplitude, as compared to the initial current. In addition, the current inhibition (red 
bars) and recovery (blue bars) as function of the treatment was statistically compared to the 
respective control condition, as indicated. The number of cells tested is indicated into brackets. 
(n.s. : non-significant). 
 
Supplementary Figure 2. Alkaline phosphatase induces the inhibition of the Cav3.3 
current and abolishes the activity-dependent Cav3.3 current inhibition.  
(A) Effect of the 1 Hz frequency stimulation on the Cav3.3 current before (1st) and after (3rd) 
~20 mn dialysis of an intracellular solution containing 100 U/ml alkaline phosphatase (AP). (B) 
Amplitude of the Cav3.3 current at the beginning (1 s) and after 40 s obtained at the 1
st and the 
3rd stimulation normalized to the initial current amplitude I (1s 1st). (C) Inactivation kinetics of 
the Cav3.3 current at the beginning of the stimulation (1 s) and after 40 s stimulation obtained 
for the 1st and the 3rd stimulation. (D) Steady-state inactivation curves of the Cav3.3 current 
obtained from control cells or cells dialyzed with AP. Asterisks indicate significant difference 
in the current amplitude (B) and inactivation kinetics (C), as compared to the initial current. In 
addition, variation in the current amplitude (B) and in inactivation kinetics (C) as function of 
the AP treatment was statistically compared to the respective control condition, as indicated. 
The number of cells tested is indicated into brackets. (n.s. : non-significant). 
 
Supplementary Figure 3. AMP-PCP does not induce rundown of the Cav3.3 current at a 
low frequency of stimulation. 
 (A) Time-course of the Cav3.3 current in cells dialyzed with 3 mM ATP or 3 mM AMP-PCP 
during low frequency of stimulation (0.0055 Hz, left panel) followed by the fast stimulation 
protocol (1Hz), which was performed 3 times (right panel). (n.s. : non-significant). 
 Supplementary Figure 4. The modulation of the Cav3.3 current at fast frequency 
stimulation is insensitive to the reducing agent dithiothreitol. 
(A-B) Typical Cav3.3 currents elicited by the 1 Hz stimulation protocol during 40 s for the 1
st 
and the 3rd stimulation in the control cells (A) and in the cells dialyzed with 1 mM dithiothreitol 
(B, DTT). (C) Amplitude of the Cav3.3 current at the beginning (1 s) and after 40 s obtained at 
the 1st and the 3rd stimulation normalized to the initial current amplitude I (1s 1st). (D) 
Inactivation kinetics of the Cav3.3 current at the beginning of the stimulation (1 s) and after 40 
s stimulation obtained for the 1st and the 3rd stimulation. Asterisks indicate significant difference 
in the current amplitude (C) and inactivation kinetics (D), as compared to the initial current. In 
addition, variation in the current amplitude (C) and in inactivation kinetics (D), as function of 
the DTT treatment, was statistically compared to the respective control condition, as indicated. 
The number of cells tested is indicated into brackets. (n.s. : non-significant). 
 
Supplementary Figure 5. The activity-dependent Cav3.3 current modulation does not 
involve PKA, PKC, Rho-associated kinase, phospholipase C, Gβ and PI3K/PI4K. 
(A) Effect of db-cAMP (1 mM, 15 minutes incubation), PMA (1 µM, 15 minutes incubation), 
chelerythrine (1 µM, 4 hours incubation), BIM IX (5 µM in the patch pipette), fasudil (10 µM, 
2 hours incubation), U73122 (10 µM in the patch pipette), edelfosine (10 µM in the patch 
pipette), PTX (0.5 µg/ml, overnight incubation), βARK expression, wortmannin (10 µM, 2 
hours incubation) and CPA (20 µM, 30 minutes incubation) on the inhibition of Cav3.3 current 
induced by the 1 Hz stimulation protocol obtained at the 3rd stimulation. The effects of the drugs 
were compared to the percent of inhibition of the Cav3.3 current obtained in the matched control 
condition. (B) Effect of db-cAMP, PMA, chelerythrine, BIM IX, fasudil, U73122, edelfosine, 
PTX, βARK expression, wortmannin and CPA on the recovery of Cav3.3 current after the 1 Hz 
stimulation protocol obtained at the beginning of the 3rd stimulation. The effects of the drugs 
were compared to the percent of recovery of the Cav3.3 current obtained in the matched control 
condition. The number of cells tested is indicated into brackets. (n.s. : non-significant). 
 
Supplementary Figure 6. Effect of various kinase inhibitors on the activity-dependent 
Cav3.3 current modulation  
(A) Effect of OSU-03012 (10 µM in the patch pipette), AKT 1/2 inhibitor (1 µM, 1 hour 
incubation), GW843682X (10 µM, 1 hour incubation), BI 2536 (1 µM, 1 hour incubation), BI-
D1870 (5 µM, 1 hour incubation), 5Z-oxozeanol (1 µM, 1 hour incubation), CGP 57380 (10 
µM, 1 hour incubation), PF-431396 (10 µM in the patch pipette), GSK 650394 (10 µM, 1 hour 
incubation), CT 99021 (1 µM, 1 hour incubation), SU6656 (1 µM, 1 hour incubation), A484954 
(10 µM, 1 hour incubation), and ML-7 (20 µM in the patch pipette) on the inhibition of Cav3.3 
current induced by the 1 Hz stimulation protocol obtained at the 3rd stimulation. The effects of 
the drugs were compared to the percent of inhibition of the Cav3.3 current obtained in the 
matched control condition. (B) Effect of the kinase inhibitors on the recovery of Cav3.3 current 
after the 1 Hz stimulation protocol obtained at the beginning of the 3rd stimulation. The effects 
of the drugs were compared to the percent of recovery of the Cav3.3 current obtained in the 
matched control condition. The number of cells tested is indicated into brackets. (n.s. : non-
significant). 
 
Supplementary Figure 7. A schematic illustration of the hypothesized mechanisms 
involved in the T-type current regulation at fast frequency stimulation.  
Stimulation of the Cav3.3 and Cav3.1 (but not Cav3.2) channels at fast frequency (1 Hz) induces 
a rise in local submembrane Ca2+. This rise in submembrane Ca2+ induces the activation of a 
putative phosphatase, whose activity produces the inhibition of the T-type current. Conversely, 
the recovery of the current depends on the activity of a yet unidentified kinase. Whether the 
Cav3 channel is directly phosphorylated or modulated via an intermediate protein remains 
unclear and requires further investigation. Action of various inhibitors used in this study is 
indicated. 
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